85235-33-2

Upstream product

• 85235-30-9 (Z)-7-[(1R,2R,3R,5S)-3-(tert-Butyl-dimethyl-silanyloxy)-2-[(E)-(S)-5-phenyl-3-(tetrahydro-pyran-2-yloxy)-pent-1-enyl]-5-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-hept-5-enoic acid tetrahydro-pyran-2-yl ester 
• 85235-31-0 (Z)-7-[(1R,2R,3R,5S)-3-(tert-Butyl-dimethyl-silanyloxy)-2-[(E)-(S)-5-phenyl-3-(tetrahydro-pyran-2-yloxy)-pent-1-enyl]-5-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-hept-5-enoic acid 
• 85235-24-1 (Z)-7-{(1R,2R,3R,5S)-3-(tert-Butyl-dimethyl-silanyloxy)-5-hydroxy-2-[(E)-(S)-5-phenyl-3-(tetrahydro-pyran-2-yloxy)-pent-1-enyl]-cyclopentyl}-hept-5-enoic acid 
• 85235-23-0 (3aR,4R,5R,6aS)-5-(tert-Butyl-dimethyl-silanyloxy)-4-[(E)-(S)-5-phenyl-3-(tetrahydro-pyran-2-yloxy)-pent-1-enyl]-hexahydro-cyclopenta[b]furan-2-ol 
• 17814-85-6 (4-carboxybutyl)triphenylphosphonium bromide 
• 85235-32-1 17-phenyl-18,19,20-trinor-PGF_2α 9,15-bis(tetrahydropyranyl ether) 

Downstream Products

• 85280-91-7 17-phenyl-18,19,20-trinor-PGD₂ 

Relevant academic research and scientific papers

Synthesis and Platelet Aggregation Inhibiting Activity of Prostaglandin D Analogues

Several prostaglandin D (PGD) analogues have been synthesized, incorpotating the following variations: (a) varying degrees of side-chain unsaturation, (b) C-9 hydroxy removed or in the unnatural 9β configuration, (c) metabolically stabilized analogues (e.